Preparation method of cilastatin sodium active pharmaceutical ingredient

A technology of cilastatin sodium and cilastatin, applied in the field of medicinal chemistry, can solve the problems of taking a long time, reducing the activity of raw materials, and taking a long time, avoiding the reduction of chemical activity and improving the quality and yield. , The effect of resin regeneration is simple

Active Publication Date: 2017-03-22
SHENZHEN HAIBIN PHARMA +1
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] In the first step, in the reaction of synthesizing cilastatin (VI), when the prior art is in industrial production, it takes a long time for the dissolution of various raw materials and the heating of the reactor, which greatly reduces the activity of the raw materials. After the reaction, each main raw material The residual amount is also relatively high, and some side reactions have also taken place during this period and generate impurities, which increases the impurity content in the reaction solution after the reaction is complete; the residual compound (Z)-7-chloro- 2-((S)-2,2-Dimethylcyclopropylformyl)-2-heptenoic acid has a large similarity with said cilastatin in terms of physical and chemical properties, making it difficult to compare its separation, resulting in an increased level of impurities in the product
[0007] In the prior art, the purification effect of the post-treatment production process of cilastatin is not good, and there are many steps, and part of the cilastatin will be lost in the post-treatment process of each step, which not only makes the yield of cilastatin low, And increased the production cost and the production cycle of cilastatin, also improved the workman's labor intensity simultaneously
[0008] In the second step, in the process of synthesizing cilastatin sodium, in the process of synthesizing cilastatin sodium by solvent method, not only sodium hydroxide needs to be completely dissolved in a certain amount of methanol, but also cilastatin needs to be dissolved in a certain amount. To dissolve in the methanol solution of cilastatin, it is necessary to slowly add methanol solution of sodium hydroxide to the methanol solution of cilastatin to adjust the pH value, which takes a long time for dissolution and a large amount of pH value adjustment time. In production, the pH value The value adjustment time is generally as high as 4-12h; during this process, cilastatin sodium will absorb too much moisture and it will take a long time to filter. In production, cilastatin sodium needs to be filtered after absorbing moisture More than 16h, cause the yield of cilastatin sodium to be on the low side and prolong the production cycle of cilastatin sodium simultaneously, increase the labor intensity of workers

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of cilastatin sodium active pharmaceutical ingredient
  • Preparation method of cilastatin sodium active pharmaceutical ingredient
  • Preparation method of cilastatin sodium active pharmaceutical ingredient

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0086] Example 1: Preparation of cilastatin sodium of the present invention

[0087] (1) Preparation of cilastatin compound represented by formula (VI):

[0088] At 0°C, 15g sodium hydroxide was added to 100g water, stirred for 10min, and then 10g compound (Z)-7-chloro-2((S)-2,2-dimethyl ring represented by formula (V) was added Propylcarboxamido)-2-heptenoic acid, stir for 10 min; add 9 g of cysteine ​​hydrochloride monohydrate at -5°C, stir for 10 min, and start the reaction at 25°C until it is analyzed by HPLC. The reaction is completed when the normalized content of (Z)-7-chloro-2((S)-2,2-dimethylcyclopropylcarboxamido)-2-heptenoic acid in the obtained reaction solution is less than 5% After cooling to 25°C, add 300g of water to the solution, stir, and slowly add 6M hydrochloric acid solution to the solution to adjust the pH to 1. The obtained solution was added to the Φ60*5.5m macroporous adsorption resin column HZ-820, first eluted with water, after the conductivity of the ...

Embodiment 2

[0091] Example 2: Preparation of cilastatin sodium of the present invention

[0092] (1) Preparation of cilastatin compound represented by formula (VI):

[0093] At 10°C, add 9g of sodium hydroxide to 80g of water, stir for 10min, and then add 10g of compound (Z)-7-chloro-2((S)-2,2-dimethyl ring represented by formula (V)) (Propylformamido)-2-heptenoic acid, stir for 10min; at 10℃, add 8.5g cysteine ​​hydrochloride monohydrate, stir for 10min, the reaction starts at 35℃, until the HPLC analysis The reaction is completed when the normalized content of (Z)-7-chloro-2((S)-2,2-dimethylcyclopropylcarboxamido)-2-heptenoic acid in the obtained reaction solution is less than 5%; After cooling to 30°C, add 250 g of water to the solution, stir, and slowly add 6M hydrochloric acid solution to the solution to adjust the pH to 1.5. The obtained solution was added to the Φ35*3.5m macroporous adsorption resin column HZ-818, first eluted with water, after the conductivity of the collected solut...

Embodiment 3

[0096] Example 3: Preparation of cilastatin sodium of the present invention

[0097] (1) Preparation of cilastatin compound represented by formula (VI):

[0098] At 0℃, add 11g of sodium hydroxide to 70g of water, stir for 10min, and then add 10g of compound (Z)-7-chloro-2((S)-2,2-dimethyl ring represented by formula (V)) (Propylformamido)-2-heptenoic acid, stir for 10min; at 0℃, add 8.3g of cysteine ​​hydrochloride monohydrate, stir for 10min, at 45℃, the reaction starts, until the HPLC analysis The reaction is completed when the normalized content of (Z)-7-chloro-2((S)-2,2-dimethylcyclopropylcarboxamido)-2-heptenoic acid in the obtained reaction solution is less than 5%; After cooling to 5°C, add 200 g of water to the solution, stir, and slowly add a 6M hydrochloric acid solution to the solution to adjust the pH to 2. The obtained solution was added to the Φ20*2.5m macroporous adsorption resin column HZ-816, and eluted with water first. After the conductivity of the collected ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a preparation method of a cilastatin sodium active pharmaceutical ingredient. The preparation method comprises the following steps: (1) mixing alkali and reaction solvent, adding a compound (Z)-7-chloro-2-((S)-2,2-dimethylcyclopropylformacyl)-2-heptenoic acid shown in Formula (V), then adding cysteine hydrochloride, reacting to obtain a reaction solution containing a compound cilastatin shown in Formula (VI); (2) purifying the reaction solution obtained in the step (1) through macroporous adsorption resin to obtain the compound cilastatin shown in Formula (VI); and (3) mixing sodium hydroxide and water, adding the cilastatin obtained in the step (2), regulating the pH value, and drying to obtain the compound cilastatin sodium shown in Formula (I). The preparation method is quick, efficient and suitable for industrial production; and the obtained cilastatin sodium active pharmaceutical ingredient is low in impurity content.

Description

Technical field [0001] The invention belongs to the technical field of medicinal chemistry, and specifically relates to a preparation method of cilastatin sodium bulk medicine. Background technique [0002] Imipenem / cilastatin sodium is widely used as a broad-spectrum antibacterial drug. The chemical name of cilastatin sodium is [R-[R*,S*(Z)]]-7-[(2-amino-2-carboxyethyl)sulfur]-2-[[(2,2- Sodium dimethylcyclopropyl)-carbonyl]amino]-2-heptenoate, its chemical structure is as shown in formula (I), and the molecular formula is C 16 H 25 N 2 NaO 5 S, the molecular weight is 380.4. The combination of cilastatin sodium and carbapenem antibiotic Imipenem can inhibit the degradation of imipenem by renal dehydropeptidase and increase the concentration of imipenem in the urinary system. Improve the activity of imipenem and reduce its nephrotoxicity. [0003] [0004] At present, the preparation methods of cilastatin sodium are all compounds represented by formula (V) (Z)-7-chloro-2-((S)-2,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07C323/59C07C319/14C07C319/28A61K31/198A61P31/04
CPCC07C319/14C07C319/28C07C323/59
Inventor 任鹏张鸣欧鹏赵勇邓华生
Owner SHENZHEN HAIBIN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap